Radiation pneumonitis in lung cancer patients treated with chemoradiation plus durvalumab.
Narek ShaverdianMaria ThorAnnemarie F ShepherdMichael D OffinAndrew JacksonAbraham J WuDaphna Y GelblumEllen D YorkeCharles B Simone IiJamie E ChaftMatthew D HellmannDaniel R GomezAndreas RimnerJoseph O DeasyPublished in: Cancer medicine (2020)
Our data suggest a delayed onset of RP in patients treated with cCRT and durvalumab vs cCRT alone, and for RP to develop in a greater number of patients treated with cCRT and durvalumab. Previously published RP models significantly underestimate the rate of symptomatic RP among patients treated with cCRT and durvalumab.